IPP Bureau
J&J to break ground on new biologics facility in North Carolina
By IPP Bureau - March 24, 2025
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
Neuland appoints Parag Deshmukh as SVP – Head of Manufacturing
By IPP Bureau - March 24, 2025
Prior to joining Neuland, Deshmukh held several key positions at Cipla
Nanomi receives CMO Award for Life Science Leadership in drug delivery
By IPP Bureau - March 22, 2025
Nanomi's pioneering approach in drug delivery has set new benchmarks in the industry, and this award serves as a motivation to continue its mission to revolutionize healthcare
SMS Pharmaceuticals completes USFDA inspection at Hyderabad facility
By IPP Bureau - March 22, 2025
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Lupin bags EcoVadis Silver Medal for sustainability excellence
By IPP Bureau - March 21, 2025
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
Glenmark receives ANDA approval for Olopatadine Hydrochloride ophthalmic solution USP, 0.2%
By IPP Bureau - March 21, 2025
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), will be distributed in the US by Glenmark Therapeutics, USA.
BrePco Biopharma and Piramal Critical Care announce MHRA approval for Neoatricon in UK
By IPP Bureau - March 21, 2025
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
Lucas Meyer Cosmetics introduces GlowCytocin to capture the science of “Love Glow”
By IPP Bureau - March 20, 2025
First-of-its-kind active cosmetic ingredient directly activates the oxytocin receptor, mimicking the dermatological effects of being in love
Indegene launches new center in London
By IPP Bureau - March 20, 2025
Zota Health Care expands Davaindia network to 1,530 stores
By IPP Bureau - March 20, 2025
The company has also launched its first three 24*7 pharmacy stores via COCO model in Bengaluru
USFDA grants Priority Review for new indication of finerenone for patients with common heart failure
By IPP Bureau - March 20, 2025
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients with heart failure
Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions
By IPP Bureau - March 20, 2025
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
ZIM Laboratories receives marketing authorization for Dimethyl Fumarate in Portugal
By IPP Bureau - March 20, 2025
Dimethyl Fumarate Modified Release Capsules are indicated for the treatment of relapsing forms of multiple sclerosis
Briefs: Dr. Agarwal's Eye Hospital and Apitoria Pharma
By IPP Bureau - March 20, 2025
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
Healthcare Triangle appoints Sujatha Ramesh as COO
By IPP Bureau - March 20, 2025
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
